Betsy Mulé is a Principal at F-Prime, where she focuses on early-stage investments in enterprise technology and robotics. Prior to joining F-Prime, she was a strategy consultant at Mars & Co. where she advised Fortune 500 companies across the US, LatAm and Europe.
Betsy is a graduate of MIT where she majored in Chemical-Biological Engineering.
Abdul is a Principal at F-Prime, where he focuses on early-stage investments in B2B software and fintech. Prior to joining F-Prime, Abdul invested in emerging markets-based technology startups and worked with a venture-backed digital banking/payments startup in East Africa. He began his career in financial services where he carried out assurance and valuations services for venture capital, private equity and hedge funds in New York & London.
Abdul holds B.A & B.S degrees from the University of Minnesota. He also holds joint MBA & MPA/ID degrees from Stanford’s Graduate School of Business and the Harvard Kennedy School.
Clay Basser-Wall is the Chief Compliance Officer of F-Prime. He has more than 20 years of legal and compliance experience. Before joining F-Prime in 2020, Clay served as the Vice President of Inside Information Compliance and Employee Trade Monitoring in Fidelity’s Ethics Office. Before that, he was an Enforcement Attorney for the U.S. Securities and Exchange Commission, where he investigated potential violations of the federal securities laws, and an Associate of the law firms of Wilson Sonsini Goodrich & Rosati, P.C., and Brobeck Phleger & Harrison, LLP, where he represented corporations and their directors and officers in securities lawsuits and SEC investigations.
Caly holds a law degree from Vanderbilt University School of Law, where he was a founding member of the Vanderbilt Journal of Entertainment Law & Practice and an Associate Justice of the Moot Court Board. He received his B.A., with honors and distinction, from Sonoma State University.
Harlan Krumholz joined F-Prime in August 2020 as a Venture Partner and is focused on transformative approaches to improve the delivery of care, conduct of research, and empowerment of people in their health decisions – and measures success by the positive, tangible effect on people’s lives. He believes in medicine as an information science and wants to advance approaches that make health care more effective, patient-centric, precise, convenient, equitable, efficient, and to position health care to be smarter with every interaction. He is the Harold H. Hines, Jr. Professor of Medicine at Yale University and the founding Director of the Yale New Haven Hospital Center for Outcomes Research and Evaluation, one of the nation’s first and most distinguished groups focusing on using applied science to improve health and healthcare. He is also a founder of two companies and an advisor for many others.
Harlan received his BS from Yale College, his MD from Harvard Medical School, and an SM from the Harvard School of Public Health.
Amber Cai is a Venture Partner with F-Prime, focusing on early-stage biotechnology investments. She is the founding CEO of Skyline Therapeutics, a leading gene and cell therapy company.
Prior to joining Skyline, Amber was a founding member of Novartis’ R&D Center in China, where she was most recently the Head of Operations and led the Center’s overall business operations overseeing a broad set of functions. During 2005-2006, Amber led the efforts to establish Novartis’ R&D presence in China from the concept stage to implementation. After the Center was established in 2006 as the first fully integrated research and development center in China by multinational pharma companies, she played an instrumental role in recruiting talent, establishing operations, developing Novartis’ China R&D strategy, and building strategic partnerships with government and other external stakeholders and collaborators. Prior to her work in China, Amber was with the Business Development at Novartis Institutes for BioMedical Researches in Cambridge, MA.
Amber has decades of experience in science before shifting her career into business. She completed her PhD at Massachusetts Institute of Technology in GPCR signaling and holds an MBA degree from MIT Sloan School of Management.
Muz Mansuri joined F-Prime in January 2020 as a Venture Partner and is based in the Cambridge office. Muz will be working with various F-Prime team members to evaluate therapeutic and digital investment and company creation opportunities. Muz has more than 35 years of experience in various R&D roles as a senior executive within the global biopharmaceutical industry.
Prior to joining F-Prime, Muz was a member of the Executive Committee at Sanofi, as Executive Vice President, Strategy, Business Development, and Licensing. Among other responsibilities, Muz headed the Strategy, Business Development, Alliance Management and the Venture Group for Sanofi. Before this, he was at Gilead Sciences as Senior Vice President, Research and Development Strategy and Business Development. In that capacity he led the R&D Strategy, Business Development, and M&A activities for the company. Muz has served as Chief Executive Officer of several biotech companies and as a General Partner at Flagship Ventures (now Flagship Pioneering). He began his career in the pharmaceutical industry as a bench medicinal chemist with Bristol Myers.
Muz received his B.Sc. and PhD in Chemistry from the University College London. He conducted postdoctoral research at UCLA and Columbia University.
Mike is Data Scientist at F-Prime, where he focuses on opportunities in healthcare technology and data science. Previously Mike worked at Beam Therapeutics, F-Prime, General Motors, and Applied Quantum Technologies.
Mike holds an M.B.A. from the University of Virginia’s Darden School of Business, an M.Eng. in Mechanical Engineering and B.S.E. in Mechanical and Electrical Engineering from Duke University.
Nikhil is a Senior Associate at F-Prime and works across the healthcare sub-sectors including therapeutics, medical technology, life sciences tools, and healthcare IT & services. Prior to joining F-Prime in 2019, Nikhil was an Associate at Audax Group in Boston, where he focused on private equity investments in healthcare and software.
Nikhil is a graduate of the University of Pennsylvania’s Vagelos Program in Life Sciences & Management, where he received a B.A. in Biology and a B.S. in Economics from the Wharton School.
Sam Bisbee is a Venture Partner at F-Prime with a background in technology, cybersecurity, and operations. He is also the Chief Security Officer at Threat Stack where he’s responsible for the company’s security and compliance programs, in addition to providing security services to Threat Stack’s Cloud SecOps Program customers.
Sam joined Threat Stack in 2014 to build and help bring the product to market. Previously Sam was a member of the Cloudant team (acquired by IBM).
Sandor is a Venture Partner at F-Prime, focusing on enterprise technology and cybersecurity. Previously he served as the CTO of LogMeIn where he drove the technology vision and development of the Identity and Remote Management portfolio (LastPass, LogMeIn Central, LogMeIn Pro, and GoToMyPC) and led the corporate IT and Security teams, navigating through many acquisitions and the merger with Citrix Online.
Sandor earned his master’s degree in Computer Science at the Budapest University of Technology and Economics and spent the early part of his career at Digital Equipment.